Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report

BACKGROUND: Non-small-cell lung cancers (NSCLCs) harboring translocations in anaplastic lymphoma kinase (ALK) are highly sensitive to small-molecule ALK kinase inhibitors, such as crizotinib. CASE PRESENTATION: We describe a case of post-operative local recurrence of lung adenocarcinoma in an 81 yea...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Res Notes
Auteurs principaux: Fukuizumi, Aya, Miyanaga, Akihiko, Seike, Masahiro, Kato, Yasuhiro, Nakamichi, Shinji, Chubachi, Kumi, Matsumoto, Masaru, Noro, Rintaro, Minegishi, Yuji, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4415237/
https://ncbi.nlm.nih.gov/pubmed/25899913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1126-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires